NOTV Stock Price, Chart, Stats & News

Inotiv, Inc.
Save
2.79M
Market cap
–
Current P/E
3.72x
Forward P/E
NOTV chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 18.10% |
Operating margin | -6.17% |
Pretax margin | -17.12% |
Net margin | -13.50% |
Effective tax rate | 21.15% |
ROA | -9.45% |
ROE | -50.77% |
D/E | 4.85x |
Interest coverage ratio | -0.56x |
NOTV valuation
P/E | – |
P/S | 0.02x |
P/B | 0.09x |
P/CF | -0.81x |
P/FCF | -0.32x |
P/OCF | -0.81x |
PEG | -0.02x |
EV multiple | -20.66x |
About
Inotiv, Inc. is a specialized life sciences company that delivers preclinical research and development solutions to the biopharmaceutical, chemical, and medical technology sectors. Additionally, it manufactures and supplies advanced analytical instrumentation for drug development and contract research organizations (CROs). The company's operations are divided into two primary divisions: Contract Research Services (CRS): This segment provides a comprehensive suite of services, including early-stage pharmacological screening, non-clinical safety assessments, formulation development support, regulatory compliance, and quality control testing.
Similar securities
Based on sector and market capitalization
Report issue











